Viatris

Viatris to provide commercial and other transition services for an expected period of two years to ensure continuity of customer…

Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee

Branded and unbranded versions of the first-ever interchangeable biosimilar in the US provide more affordable options for the…

Express Scripts, a leading pharmacy benefit management organisation, will list Viatris-labelled biosimilar Insulin Glargine as a…

While patients will be increasingly prescribed Viatris/Biocon’s Semglee over Sanofi’s Lantus due to its competitive pricing,…

Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s…

Bevacizumab inhibits the formation of tumor vasculature, thereby inhibiting tumor growth

Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1…

To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the…

Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS